Close

Deciphera Pharmaceuticals (DCPH) Reports Publication of INTRIGUE Phase 3 Clinical Study Results

Go back to Deciphera Pharmaceuticals (DCPH) Reports Publication of INTRIGUE Phase 3 Clinical Study Results
(NASDAQ: DCPH) Delayed: 14.73 +0.06 (0.41%)
Previous Close $14.67    52 Week High
Open $14.70    52 Week Low
Day High $14.84    P/E N/A 
Day Low $14.61    EPS
Volume 22,406